Market Overview:
The global mini bioreactor market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The mini bioreactor market is segmented on the basis of type, application, and region. On the basis of type, the mini bioreactor market is segmented into 0-50ML, 50-100ML, and 100-250ML segments. The 0-50ML segment is projected to account for a major share in terms of revenue in 2018 and is expected to maintain its dominance during the forecast period. This can be attributed to increasing demand for small scale reactors for R&D purposes by academic and research institutes across regions. By application, the mini bioreactor market is divided into four segments namely; Biopharmaceutical Companies CROs Academic and Research Institutes Others .
Product Definition:
A mini bioreactor is a small-scale bioprocessing device used to cultivate cells, produce biomolecules or degrade pollutants. Mini bioreactors can be used for research and development purposes, as well as for the production of therapeutic proteins and other pharmaceuticals.
0-50ML:
0-50ML is a new and unique solution in the market that allows accurate dosing of any volume from microliters to milliliters with high accuracy.
Accurate concentration measurement even at low dilutions (1/100) or higher concentrations (1/1000). This makes it useful for various applications such as protein purification, cell culture, ELISA testing and other scientific research.
50-100ML:
50-100ML is a ready to use sterile solution for the culture of microorganisms such as bacteria, algae and fungi. 50-100ML contains all the ingredients required for cell growth and can be used in any type of bioreactor system.
The global market for 50-100ML has been growing at a steady pace over the past few years owing to its increasing application in various types of bioreactors including small, medium and large scale systems.
Application Insights:
The others application segment accounted for the largest revenue share in 2017 and is anticipated to witness significant growth over the forecast period. This can be attributed to growing demand for mini bioreactors from various industries including food, beverage, cosmetics, and medical applications. Mini bioreactor finds wide applications across various industries such as pharmaceuticals & healthcare, food & beverages and cosmetics among others. The pharmaceutical companies are at present investing heavily in R&D activities with an objective to develop new products that can cure diseases but without any side effects. In order to achieve this objective a large number of clinical trials are being conducted wherein human participants are required for testing new drugs under realistic conditions similar those prevailing in a real world setting thereby driving the demand for mini bioreactors over the forecast period.
The presence of numerous academic institutions engaged in research related activities has resulted in increased focus on novel drug development which requires lab-on-chip systems that offer high throughput processing capability along with ease of maintenance.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of CROs and biopharmaceutical companies. The region is expected to maintain its dominance over the forecast period due to increasing R&D activities related to miniaturization of bioreactors. Asia Pacific is anticipated to witness lucrative growth during the forecast period owing rising awareness about advanced technologies, improving healthcare infrastructure, and increasing focus on drug discovery activities in emerging economies such as China & India. In addition, government initiatives for promoting research activities are also expected favorably impact regional market growth during the forecast period.
Growth Factors:
- Increasing demand for mini bioreactors in the pharmaceutical and biotechnology industries for drug discovery and development
- Growing popularity of single-use mini bioreactors in academic research laboratories
- Rising demand for miniaturized systems to support process intensification in the biotech industry
- Proliferation of microfluidic technology-based mini bioreactors
- Increasing use of mini bioreactors for production of therapeutic proteins and vaccines
Scope Of The Report
Report Attributes
Report Details
Report Title
Mini Bioreactor Market Research Report
By Type
0-50ML, 50-100ML, 100-250ML
By Application
Biopharmaceutical Companies, CROs, Academic and Research Institutes, Others
By Companies
Thermo Fisher, Merck KGaA, Danaher (Pall), GE Healthcare, Sartorius AG (BBI), ZETA, Eppendorf AG, Pierre Guerin (DCI-Biolafitte), Praj Hipurity Systems, Bioengineering AG, Infors HT, Applikon Biotechnology, Solaris
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Mini Bioreactor Market Report Segments:
The global Mini Bioreactor market is segmented on the basis of:
Types
0-50ML, 50-100ML, 100-250ML
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, CROs, Academic and Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- Merck KGaA
- Danaher (Pall)
- GE Healthcare
- Sartorius AG (BBI)
- ZETA
- Eppendorf AG
- Pierre Guerin (DCI-Biolafitte)
- Praj Hipurity Systems
- Bioengineering AG
- Infors HT
- Applikon Biotechnology
- Solaris
Highlights of The Mini Bioreactor Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0-50ML
- 50-100ML
- 100-250ML
- By Application:
- Biopharmaceutical Companies
- CROs
- Academic and Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mini Bioreactor Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A mini bioreactor is a small-scale device that can be used to produce biofuels or other chemicals. Mini bioreactors are often used in laboratories to study how microorganisms interact with each other and their environment.
Some of the key players operating in the mini bioreactor market are Thermo Fisher, Merck KGaA, Danaher (Pall), GE Healthcare, Sartorius AG (BBI), ZETA, Eppendorf AG, Pierre Guerin (DCI-Biolafitte), Praj Hipurity Systems, Bioengineering AG, Infors HT, Applikon Biotechnology, Solaris.
The mini bioreactor market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Mini Bioreactor Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Mini Bioreactor Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Mini Bioreactor Market - Supply Chain
4.5. Global Mini Bioreactor Market Forecast
4.5.1. Mini Bioreactor Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Mini Bioreactor Market Size (000 Units) and Y-o-Y Growth
4.5.3. Mini Bioreactor Market Absolute $ Opportunity
5. Global Mini Bioreactor Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Mini Bioreactor Market Size and Volume Forecast by Type
5.3.1. 0-50ML
5.3.2. 50-100ML
5.3.3. 100-250ML
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Mini Bioreactor Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Mini Bioreactor Market Size and Volume Forecast by Application
6.3.1. Biopharmaceutical Companies
6.3.2. CROs
6.3.3. Academic and Research Institutes
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Mini Bioreactor Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Mini Bioreactor Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Mini Bioreactor Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Mini Bioreactor Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Mini Bioreactor Demand Share Forecast, 2019-2029
9. North America Mini Bioreactor Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Mini Bioreactor Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Mini Bioreactor Market Size and Volume Forecast by Application
9.4.1. Biopharmaceutical Companies
9.4.2. CROs
9.4.3. Academic and Research Institutes
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Mini Bioreactor Market Size and Volume Forecast by Type
9.7.1. 0-50ML
9.7.2. 50-100ML
9.7.3. 100-250ML
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Mini Bioreactor Demand Share Forecast, 2019-2029
10. Latin America Mini Bioreactor Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Mini Bioreactor Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Mini Bioreactor Market Size and Volume Forecast by Application
10.4.1. Biopharmaceutical Companies
10.4.2. CROs
10.4.3. Academic and Research Institutes
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Mini Bioreactor Market Size and Volume Forecast by Type
10.7.1. 0-50ML
10.7.2. 50-100ML
10.7.3. 100-250ML
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Mini Bioreactor Demand Share Forecast, 2019-2029
11. Europe Mini Bioreactor Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Mini Bioreactor Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Mini Bioreactor Market Size and Volume Forecast by Application
11.4.1. Biopharmaceutical Companies
11.4.2. CROs
11.4.3. Academic and Research Institutes
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Mini Bioreactor Market Size and Volume Forecast by Type
11.7.1. 0-50ML
11.7.2. 50-100ML
11.7.3. 100-250ML
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Mini Bioreactor Demand Share, 2019-2029
12. Asia Pacific Mini Bioreactor Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Mini Bioreactor Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Mini Bioreactor Market Size and Volume Forecast by Application
12.4.1. Biopharmaceutical Companies
12.4.2. CROs
12.4.3. Academic and Research Institutes
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Mini Bioreactor Market Size and Volume Forecast by Type
12.7.1. 0-50ML
12.7.2. 50-100ML
12.7.3. 100-250ML
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Mini Bioreactor Demand Share, 2019-2029
13. Middle East & Africa Mini Bioreactor Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Mini Bioreactor Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Mini Bioreactor Market Size and Volume Forecast by Application
13.4.1. Biopharmaceutical Companies
13.4.2. CROs
13.4.3. Academic and Research Institutes
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Mini Bioreactor Market Size and Volume Forecast by Type
13.7.1. 0-50ML
13.7.2. 50-100ML
13.7.3. 100-250ML
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Mini Bioreactor Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Mini Bioreactor Market: Market Share Analysis
14.2. Mini Bioreactor Distributors and Customers
14.3. Mini Bioreactor Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck KGaA
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher (Pall)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GE Healthcare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sartorius AG (BBI)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ZETA
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Eppendorf AG
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pierre Guerin (DCI-Biolafitte)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Praj Hipurity Systems
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bioengineering AG
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Infors HT
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Applikon Biotechnology
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Solaris
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook